Vanguard Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $36.1M | Sell |
8,475,584
-472,223
| -5% | -$1.79M | ﹤0.01% | 2340 |
|
|
2025
Q3 | $28.5M | Sell |
8,947,807
-431,987
| -5% | -$973K | ﹤0.01% | 2450 |
|
|
2025
Q2 | $21.3M | Buy |
9,379,794
+4,262,418
| +83% | +$6.87M | ﹤0.01% | 2528 |
|
|
2025
Q1 | $3.25M | Sell |
5,117,376
-44,926
| -0.9% | -$34.8K | ﹤0.01% | 3324 |
|
|
2024
Q4 | $5.32M | Hold |
5,162,302
| – | – | ﹤0.01% | 3246 |
|
|
2024
Q3 | $6.09M | Buy |
5,162,302
+270,000
| +6% | +$343K | ﹤0.01% | 3186 |
|
|
2024
Q2 | $5.97M | Buy |
4,892,302
+34,928
| +0.7% | +$69.5K | ﹤0.01% | 3182 |
|
|
2024
Q1 | $10.6M | Sell |
4,857,374
-45,569
| -0.9% | -$84.1K | ﹤0.01% | 2933 |
|
|
2023
Q4 | $7.6M | Hold |
4,902,943
| – | – | ﹤0.01% | 3100 |
|
|
2023
Q3 | $6.32M | Hold |
4,902,943
| – | – | ﹤0.01% | 3152 |
|
|
2023
Q2 | $8.43M | Sell |
4,902,943
-12,110
| -0.2% | -$20.1K | ﹤0.01% | 3044 |
|
|
2023
Q1 | $7.42M | Buy |
4,915,053
+329,332
| +7% | +$744K | ﹤0.01% | 3108 |
|
|
2022
Q4 | $7.34M | Buy |
4,585,721
+47,760
| +1% | +$70.7K | ﹤0.01% | 3105 |
|
|
2022
Q3 | $6.58M | Sell |
4,537,961
-540,426
| -11% | -$832K | ﹤0.01% | 3168 |
|
|
2022
Q2 | $9.29M | Sell |
5,078,387
-144,499
| -3% | -$277K | ﹤0.01% | 3029 |
|
|
2022
Q1 | $13.9M | Buy |
5,222,886
+114,895
| +2% | +$441K | ﹤0.01% | 2972 |
|
|
2021
Q4 | $22.1M | Sell |
5,107,991
-408,330
| -7% | -$2.39M | ﹤0.01% | 2781 |
|
|
2021
Q3 | $28.1M | Buy |
5,516,321
+158,236
| +3% | +$847K | ﹤0.01% | 2664 |
|
|
2021
Q2 | $33.9M | Buy |
5,358,085
+697,287
| +15% | +$5.43M | ﹤0.01% | 2573 |
|
|
2021
Q1 | $36M | Buy |
4,660,798
+1,726,374
| +59% | +$13.7M | ﹤0.01% | 2486 |
|
|
2020
Q4 | $19.2M | Buy |
2,934,424
+80,236
| +3% | +$573K | ﹤0.01% | 2650 |
|
|
2020
Q3 | $19M | Buy |
2,854,188
+201,853
| +8% | +$1.5M | ﹤0.01% | 2481 |
|
|
2020
Q2 | $22.1M | Sell |
2,652,335
-58,204
| -2% | -$541K | ﹤0.01% | 2373 |
|
|
2020
Q1 | $20.8M | Buy |
2,710,539
+20,935
| +0.8% | +$146K | ﹤0.01% | 2262 |
|
|
2019
Q4 | $22.4M | Buy |
2,689,604
+80,106
| +3% | +$540K | ﹤0.01% | 2482 |
|
|
2019
Q3 | $19.3M | Sell |
2,609,498
-61,876
| -2% | -$610K | ﹤0.01% | 2508 |
|
|
2019
Q2 | $30M | Buy |
2,671,374
+259,355
| +11% | +$2.72M | ﹤0.01% | 2339 |
|
|
2019
Q1 | $25.9M | Buy |
2,412,019
+956,095
| +66% | +$14.1M | ﹤0.01% | 2389 |
|
|
2018
Q4 | $22M | Sell |
1,455,924
-1,049,063
| -42% | -$15.6M | ﹤0.01% | 2402 |
|
|
2018
Q3 | $46.3M | Buy |
2,504,987
+387,722
| +18% | +$8.83M | ﹤0.01% | 2178 |
|
|
2018
Q2 | $48.4M | Buy |
2,117,265
+653,382
| +45% | +$16.7M | ﹤0.01% | 2152 |
|
|
2018
Q1 | $41.6M | Buy |
1,463,883
+262,772
| +22% | +$7.5M | ﹤0.01% | 2164 |
|
|
2017
Q4 | $25.4M | Buy |
1,201,111
+52,905
| +5% | +$1.1M | ﹤0.01% | 2397 |
|
|
2017
Q3 | $20.9M | Buy |
1,148,206
+224,068
| +24% | +$3.5M | ﹤0.01% | 2471 |
|
|
2017
Q2 | $14.3M | Buy |
924,138
+100,607
| +12% | +$1.52M | ﹤0.01% | 2602 |
|
|
2017
Q1 | $14.2M | Buy |
823,531
+27,532
| +3% | +$362K | ﹤0.01% | 2596 |
|
|
2016
Q4 | $8.75M | Buy |
795,999
+11,353
| +1% | +$138K | ﹤0.01% | 2806 |
|
|
2016
Q3 | $12.3M | Buy |
784,646
+413,124
| +111% | +$5M | ﹤0.01% | 2589 |
|
|
2016
Q2 | $3.79M | Buy |
371,522
+141,466
| +61% | +$1.61M | ﹤0.01% | 3105 |
|
|
2016
Q1 | $2.97M | Buy |
230,056
+30,919
| +16% | +$429K | ﹤0.01% | 3214 |
|
|
2015
Q4 | $4.16M | Buy |
+199,137
| New | +$3.15M | ﹤0.01% | 3072 |
|
Other funds holding CTMX
VA
PA
KCM
CC
BBA
ACM
